Lack of beta-oxidation defects in human immunodeficiency virus-positive subjects with and without chronic zidovudine exposure.
Wachsman
M
M
Barditch-Crovo
P
P
Lietman
P S
PS
Trapnell
C B
CB
D000143:Acids / Q000652:urine; D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005234:Fatty Liver / Q000139:chemically induced / Q000209:etiology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000378:metabolism* / Q000652:urine; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced / Q000209:etiology; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction; D010865:Pilot Projects; D012306:Risk; D015215:Zidovudine / Q000009:adverse effects* / Q000494:pharmacology
D000143:Acids; D000998:Antiviral Agents; D005230:Fatty Acids, Nonesterified; D015215:Zidovudine